Metamizole (Dipyrone): Strong, Contested, and Banned in Half the World
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120

Metamizole (Dipyrone): Strong, Contested, and Banned in Half the World

Metamizole (dipyrone) in acute pain: an NNT of 2.4 at 500 mg orally, relief in over 70% against 30% on placebo (5 studies, 288 participants). Where it is sold on prescription, what is known about agranulocytosis, which signs mean stopping immediately, and what the regulator changed in December 2024.

Metamizole (Dipyrone): Strong, Contested, and Banned in Half the World
Metamizole (dipyrone) is regarded as a good painkiller: in the 2016 Cochrane review (5 studies, 288 participants), 500 mg orally relieved at least half the pain in over 70% of participants against 30% on placebo. Where it is sold on prescription, what is known about agranulocytosis, which signs mean stopping immediately, and what the German regulator changed in December 2024.

Key points

Metamizole (dipyrone) is a painkiller that German doctors prescribe often, on prescription since 1987. The table shows what is known about it in people.

WhereHow it helpsWhat human studies showed
Acute painrelieves pain; its reputation as a strong agent is not baseless2016 Cochrane review, 500 mg orally: at least half the pain relieved in over 70% of participants against 30% on placebo; NNT 2.4 (95% CI 1.8–3.1), moderate certainty; 5 studies, 288 participants, 143 on the 500 mg dose

How it helps

Acute pain

The figures in «Key points» come from the 2016 Cochrane review, and they are good: metamizole is regarded as a good analgesic, and its reputation as a strong agent is not baseless.

Track record

In Germany metamizole is prescribed to millions — on prescription since 1987.

How to take it

Metamizole is a prescription drug: the prescribing stays with a doctor. The figures in «Key points» refer to the 500 mg oral dose.

  • Treat it differently from an over-the-counter painkiller, and do not take it long-term on your own initiative.
  • Know in advance the signs that mean stopping immediately — they are in «Who should see a doctor first».

Where it is sold

  • Germany — prescription since 1987 (Novalgin, Novaminsulfon and generics).
  • Italy — registered (Novalgina and others), all forms on prescription, paid entirely by the patient.
  • France — not sold: no valid authorisation.
  • United States — withdrawn from the market in 1977.

The drug is in the catalogue: Novalgina (metamizole) 500 mg. No price is shown — prescription medicines are ordered through the chat, and the administrator confirms availability and cost.

Who should see a doctor first

Agranulocytosis: what it is and how likely

Agranulocytosis is a sharp fall in neutrophils, the cells that defend against bacterial infection. A person becomes defenceless against ordinary flora, and untreated the condition is life-threatening.

The German label classes the frequency as «very rare» — up to one case in 10,000. That is rare, with two features that make it contentious: the reaction is unpredictable, and it can arise at any point during treatment and shortly after it ends.

What the regulator changed in December 2024

On 9 December 2024 the German regulator issued an official notice, agreed with the European agency, on measures to reduce the consequences of this risk.

The most interesting part is what many expected and did not get: routine blood monitoring during treatment was dropped. Instead, contraindications and warnings were tightened, and the main weight was placed on informing the patient. The logic is that the reaction develops too fast to be caught by scheduled tests; the only person who can catch it is the patient who knows the signs.

Signs that mean stopping immediately:

  • fever and chills with no clear cause;
  • sore throat;
  • painful changes to the mucous membranes — mouth, nose, throat, and also the genital and anal area.

If any appear, stop the drug and see a doctor the same day: a full blood count with differential is required. Treatment is not resumed until the result is in. If the diagnosis is confirmed, it is never resumed.

A specific trap, named in the notice itself: when the drug is taken for fever, or alongside antibiotics, the symptoms can be masked. Someone takes it for a temperature — and temperature as a warning sign disappears into that.

Bottom line

Metamizole genuinely relieves pain well, and its reputation as a strong agent is not baseless.

It deserves different treatment from an over-the-counter painkiller: know the signs that mean stopping at once, and do not take it long-term on your own initiative.

Source: Metamizole (Dipyrone): Strong, Contested, and Banned in Half the World — universum.earth. Dr. Pereligyn.

Come back
Request a call back